Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031427 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aung Khine Linn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Excellent Center for Drug Discovery, Faculty of Science, Mahidol University, Bangkok 10400, Thailand. Hauptthemen laut MEDLINE: COVID-19, Induced Pluripotent Stem Cells, Heart Diseases, Chalcones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, NXPO, Program Management Unit for Human Resources & Institutional Development, Research and Innovation, NXPO, Ramathibodi Foundation.
Abstract (Originalsprache)
Establishing a drug-screening platform is critical for the discovery of potential antiviral agents against SARS-CoV-2. In this study, we developed a platform based on human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to investigate SARS-CoV-2 infectivity, with the aim of evaluating potential antiviral agents for anti-SARS-CoV-2 activity and cardiotoxicity. Cultured myocytes of iPSC-CMs and immortalized human cardiomyocyte cell line (AC-16) were primarily characterized for the expression of cardiac markers and host receptors of SARS-CoV-2. An infectivity model for the wild-type SARS-CoV-2 strain was then established. Infection modeling involved inoculating cells with SARS-CoV-2 at varying multiplicities of infection (MOIs) and then quantifying infection using immunofluorescence and plaque assays. Only iPSC-CMs, not AC16 cells, expressed angiotensin-converting enzyme 2 (ACE-2), and quantitative assays confirmed the dose-dependent infection of iPSC-CMs by SARS-CoV-2, unlike the uninfectable AC16 cells lacking the expression of ACE2. Cytotoxicity was evaluated using MTT assays across a concentration range. An assessment of the plant-derived compound panduratin A (panA) showed cytotoxicity at higher doses (50% cytotoxic concentration (CC50) 10.09 μM) but promising antiviral activity against SARS-CoV-2 (50% inhibition concentration (IC50) 0.8–1.6 μM), suppressing infection at concentrations 10 times lower than its CC50. Plaque assays also showed decreased viral production following panA treatment. Overall, by modeling cardiac-specific infectivity, this iPSC-cardiomyocyte platform enables the reliable quantitative screening of compound cytotoxicity alongside antiviral efficacy. By combining disease pathogenesis and pharmacology, this system can facilitate the evaluation of potential novel therapeutics, such as panA, for drug discovery applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Excellent Center for Drug Discovery, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
- Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
- Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
- Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
- Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
- Department of Anatomy, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
ORCID-Profile: Aung Khine Linn, Suwimon Manopwisedjaroen, Suradej Hongeng, Phetcharat Phanthong, Arunee Thitithanyanont
Förderung
- the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, NXPO
- Program Management Unit for Human Resources & Institutional Development, Research and Innovation, NXPO
- Ramathibodi Foundation
Zitieren
APA
Linn, A. K., Manopwisedjaroen, S., Kanjanasirirat, P., Borwornpinyo, S., Hongeng, S., Phanthong, P., & Thitithanyanont, A. (2024). Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031427
Vancouver
Linn AK, Manopwisedjaroen S, Kanjanasirirat P, Borwornpinyo S, Hongeng S, Phanthong P, et al. Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031427
BibTeX
@article{Linn2024,
author = {Linn, Aung Khine and Manopwisedjaroen, Suwimon and Kanjanasirirat, Phongthon and Borwornpinyo, Suparerk and Hongeng, Suradej and Phanthong, Phetcharat and Thitithanyanont, Arunee},
title = {Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031427}
}
EUVIMED